Vertex Pharmaceuticals Incorporated is categorized under Commercial Medical Research in Cambridge, MA .
Vertex Pharmaceuticals Incorporated was established in 0, and today employs 1 to 4, earning Unknown per year. This is a Commercial Medical Research business, which does work in the B2B market, and is classified as a Commercial Medical Research, under code number 541712 by the NAICS.
If you are seeking more information, feel free to contact Eric Bell at the company’s branch by writing to 200 Sidney St, Cambridge, Massachusetts MA 02139 or by phoning (617) 444-6100. You can also visit this business on Facebook by going to their profile page at Facebook or on find them on Twitter.
| Business Name: | Vertex Pharmaceuticals Incorporated |
| Contact Person: | Eric Bell |
| Address: | 200 Sidney St, Cambridge, Massachusetts 02139 |
| Phone Number: | (617) 444-6100 |
| Website Address: | investors.vrtx.com |
| Annual Revenue (USD): | Unknown |
| Location Type: | Branch |
| Employee Number: | 1 to 4 |
| Business Type: | B2B (Business to Business) |
| Business Category: | Commercial Medical Research |
| SIC Code: | 8731 |
| NAICS Code: | 541712 |
| Share This Business: |
Vertex Pharmaceuticals Incorporated was started in 0 to provide professional Commercial Medical Research under the SIC code 8731 and NAICS code 541712. Since its inception, the company has gone on to take a total of 1 to 4 personnel under its employment and has achieved earnings of Unknown per annum.
Feel free to contact Eric Bell for inquiries that concern Vertex Pharmaceuticals Incorporated by calling the company number (617) 444-6100, as your correspondence is most welcome. Additionally, the physical location of the branch of Vertex Pharmaceuticals Incorporated can be found at the coordinates 42.358058,-71.105001 as well as the street address 200 Sidney St in Cambridge, Massachusetts 02139.
For its online presence, you may visit Vertex Pharmaceuticals Incorporated’s website at investors.vrtx.com and engage with its social media outlets through on Twitter and on Facebook.